| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Traws Pharma, Inc. | Director | Common Stock | 109,222 | $279,608 | $2.56 | 12 Dec 2025 | Direct |
| Traws Pharma, Inc. | Director | Series A Warrant (right to buy) | 96,348 | 29 Dec 2024 | Direct | ||
| Traws Pharma, Inc. | Director | Stock Option (right to purchase) | 19,496 | 12 Dec 2025 | Direct | ||
| Traws Pharma, Inc. | Director | Pre-Funded Warrant (right to buy) | 0 | 18 Feb 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TRAW | Traws Pharma, Inc. | 12 Dec 2025 | 2 | $0 | 4 | Director | 16 Dec 2025, 18:21 |
| TRAW | Traws Pharma, Inc. | 12 Oct 2025 | 1 | $0 | 4 | Director | 15 Oct 2025, 20:06 |
| TRAW | Traws Pharma, Inc. | 19 Jun 2025 | 1 | $0 | 4 | Director | 23 Jun 2025, 17:50 |
| TRAW | Traws Pharma, Inc. | 18 Feb 2025 | 2 | +$963 | 4 | Chief Executive Officer, Director | 19 Feb 2025, 18:23 |
| TRAW | Traws Pharma, Inc. | 29 Dec 2024 | 2 | $0 | 4 | Chief Executive Officer, Director | 27 Jan 2025, 19:02 |
| TRAW | Onconova Therapeutics, Inc. | 01 Apr 2024 | 1 | $0 | 4 | Chief Executive Officer, Director | 03 Apr 2024, 20:03 |
| TRAW | Onconova Therapeutics, Inc. | 01 Apr 2024 | 0 | $0 | 3 | Chief Executive Officer, Director | 03 Apr 2024, 19:53 |